ACR Meeting Abstracts
Abstract Number: 2656 • ACR/ARHP Annual Meeting 2018
José Luis Martín-Varillas1, Belén Atienza-Mateo1, Javier Loricera2, Monica Calderón Goercke3, Diana Prieto Peña3, Susana Armesto2, Eduardo Cuende4, Carmen González-Vela2, José Luis Hernández2, Miguel Angel González-Gay2 and Ricardo Blanco1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 3Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 4University Hospital Príncipe de Asturias, Immune System Diseases, Rheumatology department, Alcalá de Henares, Madrid, Spain
Background/Purpose: Skin lesions of lupus may be refractory to standard therapy. Apremilast is an orally small molecule which inhibits phosphodiesterase-4 (PDE-4) that modulates some inflammatory…